3 ms·
Maybe they are, but there are hurdles in getting them to market. Here's an example about Merck's suvorexant. http://www.newyorker.com/magazine/2013/12/09/the-
by mrbill 12y ago
Maybe they are, but there are hurdles in getting them to market. Here's an example about Merck's suvorexant.
http://www.newyorker.com/magazine/2013/12/09/the-big-sleep-2 http://www.newyorker.com/magazine/2013/12/09/the-big-sleep-2